Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

Bishop Grants Mass Exemption Amid Trump ICE Raids

July 9, 2025

Tulsi Gabbard Highlights Energy in Historic First Trump Cabinet Meeting

February 26, 2025

Democrats Hold Trump Responsible for Iran-Israel Tensions as GOP Calls for Strong Stance

June 20, 2025

Climate Activists Vandalize NYC Tesla Dealership on Earth Day

April 22, 2025

Trump Claims Gaza Ceasefire Possible Within Week

June 27, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • Blue County Faces Backlash After ICE Arrests Serial Offender with 10 Prior Arrests
  • Texas Girl Fends Off Attempted Abduction by Biting Attacker
  • Hurricane Melissa Strikes Jamaica with Severe Winds and Rain, Moves Toward Cuba
  • 5 Key Tips for Protecting Your Online Privacy on Social Media
  • Portland Statue Controversy Concludes with Reinstatement Decision
  • Lithuanian FM Urges EU to Strengthen Eastern Defense Amid Rising Tensions
  • Nvidia AI Chips Enter Full Production in Arizona
  • Severe Flooding Strands Residents and Disrupts Life in Seven Provinces
  • U.S. Strikes Four Alleged Drug Boats in Pacific, Killing 14 and Leaving One Survivor
  • Amazon to Cut 14,000 Jobs Amid AI Integration Efforts
  • Bob Mackie Reflects on Iconic Career Designing for Legends Like Tina Turner and Cher
  • Louisiana Residents Concerned About Rising Energy Costs and Meta AI Data Center Construction
  • Netanyahu Commands Intensified Gaza Strikes After Ceasefire Breach
  • Trump Dismisses Oversight Board for D.C. Construction Amid Plans for White House Changes
  • European Stocks Decline Despite FTSE 100 Reaching Record High
  • Stocks to Watch: After-Hours Movers Include Visa, Seagate, Caesars, and Mondelez
  • Activist Investor Targets Underperforming U.S. Banks
  • Transgender Rabbi with Iranian Allegations Supports NYC Mayoral Candidate
  • Florida Breaks Execution Record with 15th Inmate this Year
  • Hurricane Melissa poses severe flood and landslide risk to Jamaica, Haiti, and Cuba
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Wednesday, October 29
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » Top Stories » America’s Top 10 Most Expensive Prescription Medications by Cost and Volume
America's Top 10 Most Expensive Prescription Medications by Cost and Volume

America’s Top 10 Most Expensive Prescription Medications by Cost and Volume

News EditorBy News EditorMay 13, 2025 Top Stories 7 Mins Read

In a bid to make healthcare more affordable, President Donald Trump has unveiled an executive order aimed at lowering prescription drug prices in the United States. The initiative introduces a “most favored nations drug pricing” model, which seeks to ensure that American consumers pay no more than the lowest price for drugs available in other developed nations. With the promise of potential reductions of up to 90% on certain medications, this announcement has drawn both optimism and skepticism from various stakeholders in the healthcare sector.

Article Subheadings
1) Executive Order Aims to Lower Drug Prices
2) Overview of the Most Expensive Drugs
3) Potential Changes in Drug Pricing Landscape
4) Implications for Pharmaceutical Innovation
5) Expert Opinions on the New Pricing Model

Executive Order Aims to Lower Drug Prices

On Monday, President Trump announced an executive order that is designed to cut the prices of prescription medications across the country. The initiative does not bring about immediate pricing changes; rather, it directs federal agencies to start the regulatory process needed to implement these new pricing strategies. Trump emphasized, “Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%,” highlighting the administration’s relentless pursuit to reduce the financial burden on American consumers.

The cornerstone of this approach is what is termed “most favored nations drug pricing.” This means that the price for medications that Americans pay will be aligned with the lowest prices found in other developed countries. The goal is to address the inequality faced by American patients who often pay significantly higher prices compared to their counterparts abroad.

Explaining its significance, Katy Dubinsky, a New York pharmacist and founder of Vitalize, expressed her support for the executive order but cautioned, “But this will not be simple to accomplish.” She noted that while the intent is clear, the execution will likely involve a lengthy and complex regulatory framework. Time will tell how efficiently this order will translate to lower prices in pharmacy aisles.

Overview of the Most Expensive Drugs

In the evolving context of drug prices, awareness of the current costs of medications is crucial. According to Dubinsky, the following list includes some of the most expensive medications currently available in the United States:

1. Lenmeldy (atidarsagene autotemcel) by Orchard Therapeutics – $4.25 million

This groundbreaking medication is utilized for treating metachromatic leukodystrophy (MLD), a serious genetic disorder that results in severe neurological issues in children. It is a one-time treatment designed to halt or significantly slow the progression of the disease.

2. Hemgenix (etranacogene dezaparvovec-drlb) by CSL Behring – $3.5 million

Administered as a one-time therapy, Hemgenix facilitates the body’s ability to generate its own clotting factor, making it a transformative treatment for individuals suffering from hemophilia B.

3. Elevidys (delandistrogene moxeparvovec-rokl) by Sarepta Therapeutics – $3.2 million

Targeted at young boys with Duchenne muscular dystrophy (DMD), this medication aims to slow down the progression of the disease, which can drastically weaken muscles over time.

4. Skysona (elivaldogene autotemcel) by Bluebird Bio – $3 million

This medication addresses cerebral adrenoleukodystrophy (CALD), a debilitating neurological condition predominantly affecting boys. The treatment aims to delay the adverse effects of the disease before they become severe.

5. Zynteglo (betibeglogene autotemcel) by Bluebird Bio – $2.8 million

For blood conditions like beta-thalassemia, which often necessitate lifelong transfusions, Zynteglo presents an innovative approach that enables patients to produce their own red blood cells.

Potential Changes in Drug Pricing Landscape

The announcement of Trump’s executive order heralds potential transformation in how medications are priced in the United States. However, experts like Dr. Jacob Glanville, CEO of Centivax, caution that immediate changes may not be pervasive. Vaccines and many generic drugs are likely to remain unaffected, as most cost significantly less than their brand-name counterparts.

Dr. Glanville highlights that the order may particularly impact newer, brand-name drugs still under patent exclusivity. These include cutting-edge therapies like antibody and cellular treatments, gene therapies, and personalized cancer vaccines, often resulting in prohibitively high costs—sometimes ranging from $100,000 to $500,000 per treatment course.

While the prospect of lower prices is welcomed by many, questions arise about its sustainability and long-term ramifications. Pharmaceutical companies might argue that reducing drug costs could deter investment in innovation, thereby limiting the development of new treatments that could benefit public health.

Implications for Pharmaceutical Innovation

The pharmaceutical industry is a sector where research and development expenses can soar, costing companies billions to bring a new drug to market. Experts predict a reduction in budgets for clinical trials and drug manufacturing if prices are capped. As voiced by Dr. Glanville, “If the prices of new medicines are capped, then effort should be made to reduce the cost of clinical trials and drug GMP manufacturing. Otherwise, we will lose a lot of innovation.”

The delicate balance between accessibility and encouraging pharmaceutical innovation lies at the heart of this new pricing strategy. As larger pharmaceutical companies leverage higher prices to fund research, there is a palpable concern that caps could stifle the quest for groundbreaking medical treatments in fields that offer high-risk, high-reward potential.

Expert Opinions on the New Pricing Model

The healthcare community is divided over the proposed changes. On one hand, advocates for lower drug prices argue that current costs are unsustainable, placing excessive financial strain on patients and families alike. “From a patient’s perspective, the price of medical care in the United States is unsustainable,” stated one expert.

On the other hand, industry representatives argue that immediate price reductions could inadvertently hinder the long-term development of new therapies and innovations.

“If the industry cannot recoup the costs of development, investment in future medications may dwindle,” said another analyst.

As stakeholders continue to debate the merits and drawbacks of Trump’s executive order, the unfolding landscape of drug pricing in America remains uncertain. Observers across the healthcare spectrum will monitor how these changes impact the cost of prescription drugs as regulations develop.

No. Key Points
1 The executive order aims to introduce a “most favored nations drug pricing” model in the U.S.
2 Some medications could see price reductions of up to 90%.
3 The most expensive medications can cost millions and include innovative gene therapies.
4 Experts warn that lowering drug prices may impact pharmaceutical innovation and investment.
5 The healthcare community is divided on the efficacy and sustainability of the pricing changes.

Summary

President Trump’s executive order seeks to drastically alter the drug pricing landscape in the United States by ensuring patients pay no more than the lowest price available in other developed countries. While it promises significant reductions, the operational complexities and potential ramifications for pharmaceutical innovation remain to be seen. As the regulatory framework unfolds, the forthcoming months will be pivotal in determining how these ambitious goals translate into real-world pricing and accessibility for American patients.

Frequently Asked Questions

Question: What does the executive order involve?

The executive order focuses on implementing “most favored nations drug pricing,” ensuring Americans pay the lowest prices for medications compared to other developed countries.

Question: How do current drug prices impact patients?

Current drug prices in the U.S. can be prohibitively high, often leading to financial strain for patients and families trying to manage healthcare costs.

Question: What are the concerns related to lowering drug prices?

Experts worry that capping drug prices may reduce investment in pharmaceutical innovation, potentially leading to fewer new treatments being developed.

Americas Breaking News cost Critical Events Economic Trends Exclusive Reports Expensive Global Headlines Hot Topics In-Depth Stories Investigative News Latest Headlines Live Updates Local Highlights Major Announcements Medications National Updates Opinion & Analysis Political Developments Prescription Social Issues Special Coverage Top Top Stories Trending Topics Viral News Volume
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

Top Stories

Portland Statue Controversy Concludes with Reinstatement Decision

5 Mins Read
Top Stories

Trump Dismisses Oversight Board for D.C. Construction Amid Plans for White House Changes

6 Mins Read
Top Stories

Putin Appoints Family Members to Key Positions Amid Kremlin Instability Concerns

6 Mins Read
Top Stories

Trump Praises “Very Fair” Trade Deal with Japan in Meeting with New Prime Minister

7 Mins Read
Top Stories

Two Victims Identified in Fatal California Crash Linked to Illegal Immigration

6 Mins Read
Top Stories

Homecoming Shooting at Pennsylvania University Leaves One Dead and Six Injured

4 Mins Read
Journalism Under Siege
Editors Picks

Trump Reportedly Fears ‘Bold Black Women,’ According to Crockett

May 4, 2025

Former DOJ Lawyer Cautions Trump Administration on Legal Strategies

March 22, 2025

Acting U.S. Attorney for D.C. Faces Backlash Over Prosecutor Demotions and Controversial Messages

March 3, 2025

Appeals Court Maintains Hold on Trump Administration’s Transgender Military Ban During Ongoing Legal Challenge

April 1, 2025

Trump Pays Tribute to Fallen Heroes, Promises to Restore Nation Before 250th Anniversary

May 26, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.
Go to mobile version